| Adenosine | |||||||||||||
| Endogenous nucleoside antidysrhythmic which acts by slowing conduction through the AV node, interrupting AV nodal re-entry pathway circuit. | |||||||||||||
| Indications: Symptomatic PSVT | |||||||||||||
| Contraindications: Hypersensitivity 2nd or 3rd degree AV Block Sick Sinus Syndrome Atrial flutter Atrial fibrillation |
|||||||||||||
| Common Side Effects: Nausea, dyspnea, chest pressure, facial flushing Potentially Lethal Side Effects: Atrial tachydysrythmias |
|||||||||||||
| Adult dosing (ACLS): Rapid IV with Rapid IV flush Dose 1: 6mg Doses 2 and 3: 12mg |
|||||||||||||
| Pediatric dosing (PALS): Rapid IV/IO with Rapid flush Dose 1: 0.1 mg/kg Max 6mg Dose 2: 0.2 mg/kg Max 12mg |
|||||||||||||
| Notes: - Use medium-to-large bore, short catheter - Medication port flush with 10cc NaCl using >18 ga needle - Precede with vagal maneuvers in stable patients. - Consider synchronized DC cardioversion in unstable patients |
|||||||||||||